A Role for Endothelin-1 in Peripheral Vascular Disease
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
325-332
Author(s):
Janice C.S. Tsui and Michael R. Dashwood
Endothelin-1 and Human Platelets
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
393-399
Author(s):
I. Anita Jagroop, Stella S. Daskalopoulou and Dimitri P. Mikhailidis
Clinical Aspects and Therapeutic Perspectives of Relaxin
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
403-410
Author(s):
D. Bani and M. Bigazzi
Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3185-3199
Author(s):
T. Minko, Y. Wang and V. Pozharov
Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2199-2208
Author(s):
Aurelio Leone
The Predictive Value of Lipid Markers in Vascular Disease
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2209-2224
Author(s):
H. J. Milionis, S. S. Daskalopoulou, M. Elisaf and D. P. Mikhailidis
Microcirculation of the Diabetic Foot
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2301-2309
Author(s):
T. Dinh and A. Veves
Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2331-2365
Author(s):
C. Watala
ATP-Sensitive Potassium Channels
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1915-1940
Author(s):
G. C. Rodrigo and N. B. Standen
Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway
Journal:
Current Pharmacogenomics
Volume:
3
Page:
119-128
Author(s):
Tianhua Niu and Simin Liu